Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: A case report - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Transplant Infectious Disease Année : 2017

Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: A case report

Résumé

Chronic disseminated candidiasis (CDC) is a rare and difficult‐to‐treat invasive fungal disease occurring mainly after prolonged and profound neutropenia. We describe the case of a 59‐year‐old man successfully treated with thalidomide for CDC recurrences after an autologous transplantation. We add evidence of the effectiveness of immunomodulatory drugs to manage inflammatory reconstitution immune syndrome‐related refractory CDC.
Fichier non déposé

Dates et versions

hal-02430611 , version 1 (07-01-2020)

Identifiants

Citer

Blandine Rammaert, Sophie Candon, Christophe Maunoury, Marie-Elisabeth Bougnoux, Gregory Jouvion, et al.. Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: A case report. Transplant Infectious Disease, 2017, 19 (1), pp.e12637. ⟨10.1111/tid.12637⟩. ⟨hal-02430611⟩
46 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More